Brief: Marksans Pharma Reports March-Quarter Consol Net Profit Of 905.5 Million Rupees
19/05/2025 16:33
May 19 (Reuters) - Marksans Pharma Ltd MARK.NS: MARCH-QUARTER CONSOL NET PROFIT 905.5 MILLION RUPEES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 7.08 BILLION RUPEES Source text: ID:nBSEc9rR4n Further company coverage: MARK.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg